מכפיל P/S עתידי: STRATA Skin Sciences Inc. (SSKN)

STRATA Skin Sciences (SSKN) supplies laser systems for the treatment of vitiligo and psoriasis to clinics. The forward P/S ratio reflects market expectations, where 0.00 becomes the new value of the metric. Revenue is based on the sale of devices and consumables, which stabilizes cash flow. However, the limited capital of physicians restricts the growth of procedure fees, weakening the issuer's pricing power.

Moderate cyclicality in demand for STRATA Skin Sciences (SSKN) laser systems and stable revenue from consumables make the capitalization-to-forecasted-revenue ratio a key tool for assessing business resilience. The trend in the expected price-to-sales ratio allows investors to determine the asset's current margin of safety and promptly identify either the emergence of an investment discount or a systemic deterioration of the company's fundamental indicators.